Active Ingredient(s):Radium Ra-223 Dichloride FDA Approved: * May 15, 2013 Pharm Company: *BAYER HLTHCARE Category:Cancer
Radium-223 (223Ra, Ra-223) is an isotope of radium with an 11.4-day half-life. It was discovered in 1905 by T. Godlewski, a Polish chemist from Kraków, and was historically known as actinium X (AcX). Radium-223 dichloride is an alpha particle-emitting radiotherapy drug that mimics calcium and forms complexes with hydroxyapatite at areas of increased bone turnover. The princi...
* May have multiple approval dates, manufacturers, or labelers.